OncoCyte
OCX
$2.48
Share price
1.64%
Change (1 day)
818.52%
Change (1 year)
Categories
Operating Margin for OncoCyte (OCX)
Operating Margin as of April 2024 (TTM): -1,942.79%
According to OncoCyte 's latest financial reports and stock price the company's current Operating Margin is -1,942.79%. At the end of 2021 the company had an Operating Margin of -949.37%.
Operating Margin history for OncoCyte from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -949.37% | -62.98% |
| 2020 | -2,564.64% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.